193 related articles for article (PubMed ID: 9567343)
1. Retrovirus-host interactions. The mouse mammary tumor virus model.
Acha-Orbea H
Medicina (B Aires); 1997; 57 Suppl 2():43-52. PubMed ID: 9567343
[TBL] [Abstract][Full Text] [Related]
2. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
3. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
4. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B
Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342
[TBL] [Abstract][Full Text] [Related]
5. Superantigens and retroviral infection: insights from mouse mammary tumor virus.
Held W; Acha-Orbea H; MacDonald HR; Waanders GA
Immunol Today; 1994 Apr; 15(4):184-90. PubMed ID: 8198710
[TBL] [Abstract][Full Text] [Related]
6. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
7. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
8. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
9. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
10. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
[TBL] [Abstract][Full Text] [Related]
11. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
[TBL] [Abstract][Full Text] [Related]
12. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
Nepomnaschy I; Buggiano V; Goldman A; Deroche A; Bekinschtein P; Berguer P; Piazzon I
Medicina (B Aires); 1997; 57(3):327-31. PubMed ID: 9640768
[TBL] [Abstract][Full Text] [Related]
13. [Superantigens and murine mammary tumor retrovirus].
Piazzon I; Nepomnaschy I; Buggiano V; Bekinschtein P; Goldman A; Berguer P; Deroche A; Lombardi G
Medicina (B Aires); 1997; 57 Suppl 2():21-33. PubMed ID: 9567341
[TBL] [Abstract][Full Text] [Related]
14. B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection.
Ardavín C; Martín P; Ferrero I; Azcoitia I; Anjuère F; Diggelmann H; Luthi F; Luther S; Acha-Orbea H
J Immunol; 1999 Mar; 162(5):2538-45. PubMed ID: 10072493
[TBL] [Abstract][Full Text] [Related]
15. Immune response to MMTV infection.
Acha-Orbea H; Shakhov AN; Finke D
Front Biosci; 2007 Jan; 12():1594-609. PubMed ID: 17127406
[TBL] [Abstract][Full Text] [Related]
16. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.
Ardavin C; Luthi F; Andersson M; Scarpellino L; Martin P; Diggelmann H; Acha-Orbea H
J Virol; 1997 Oct; 71(10):7295-9. PubMed ID: 9311805
[TBL] [Abstract][Full Text] [Related]
18. Gradual elimination of retroviruses in YBR/Ei mice.
MacDearmid CC; Case LK; Starling CL; Golovkina TV
J Virol; 2006 Mar; 80(5):2206-15. PubMed ID: 16474128
[TBL] [Abstract][Full Text] [Related]
19. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
20. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
Bhadra S; Lozano MM; Dudley JP
J Virol; 2009 Jan; 83(1):484-8. PubMed ID: 18922863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
